Clinical Trials Directory

Trials / Completed

CompletedNCT04337268

Acute Effects of GLP-1 on Renal Hemodynamics

Acute Effects of GLP-1 on Renal Hemodynamics: Simultaneous Perfusion and Oxygenation Measurements in Cortex and Medulla Using Magnetic Resonance Imaging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study investigates the hypothesis, that GLP-1's suppression of ANG II and natriuretic action increase medullary perfusion and decrease oxygen consumption, leading to higher tissue oxygenation.

Detailed description

Human studies have recently demonstrated a significant natriuretic effect of GLP-1 when the extracellular fluid volume (ECFV) is expanded by intravenous sodium-loading; in these studies, there was a suppression of ANG II with no change in net renal hemodynamics, pointing to a tubular mechanism for reduced NaCl reabsorption secondary to the ANG II suppression. In the current randomized and controlled study, investigators aim to test the hypothesis that GLP-1's suppression of ANG II and natriuretic action increase medullary perfusion and decrease oxygen consumption, leading to higher tissue oxygenation. Thus, contributing to the renoprotective action of GLP-1. Under fixed sodium intake for 4 days before each study day, 10 healthy male participants will be investigated during a 1-hour infusion of GLP-1 (1.5 pmol/kg/min) or vehicle together with an intravenous infusion of 0.9% NaCl. Interleaved measurements of RAF, oxygenation (T2\*) and perfusion by arterial spin labeling in the renal cortex and medulla at fixed time points will be conducted, using Magnetic Resonance Imaging (MRI).

Conditions

Interventions

TypeNameDescription
DRUGGlucagon-Like Peptide 1Intravenous infusion (1.5 pmol/kg/min) for 60 min.
DRUGsaline 0.9%Intravenous infusion for 60 min.

Timeline

Start date
2019-04-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2020-04-07
Last updated
2020-04-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04337268. Inclusion in this directory is not an endorsement.